Company Filing History:
Years Active: 2025
Title: Albert Brennauer: Innovator in Pharmaceutical Sciences
Introduction
Albert Brennauer is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of soluble NPY2 receptor agonists. His work has implications for medical applications, showcasing his innovative spirit and dedication to advancing healthcare.
Latest Patents
Albert Brennauer holds a patent for "Soluble NPY2 receptor agonists." This invention relates to PYY analogues that feature alanine at position 4, lysine at position 7, QRY as the C-terminal end, and a half-life extending group. The analogues are designed to be soluble around pH 6 and 7. Additionally, the invention encompasses pharmaceutical compositions that include these PYY analogues, along with their medical uses.
Career Highlights
Brennauer is currently associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to leverage his expertise in drug development and innovation. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Some of his notable coworkers include Peter Wilhelm Haebel and Stefan Peters. Their collaborative efforts contribute to the innovative environment at Boehringer Ingelheim, fostering advancements in pharmaceutical research.
Conclusion
Albert Brennauer exemplifies the spirit of innovation in the pharmaceutical industry. His work on soluble NPY2 receptor agonists highlights his commitment to improving medical treatments. Through his career and collaborations, he continues to make a significant impact in the field.